Table 3. DNA content in patient material divided according to high and low Cdc20 and securin immunoexpression (n=445).
| Diploid | Aneuploid | Tetraploid | P | 5cERa | P | |
|---|---|---|---|---|---|---|
| High Cdc20 expression |
6% |
63% |
31% |
0.059 |
75% |
0.045 |
| Low Cdc20 expression |
28% |
36% |
36% |
|
49% |
|
| High securin expression |
15% |
45% |
40% |
0.002 |
67% |
<0.001 |
| Low securin expression |
35% |
32% |
33% |
|
39% |
|
| High Cdc20 and securin |
0% |
67% |
33% |
0.005 |
92% |
<0.001 |
| Low Cdc20 and securin | 35% | 32% | 33% | 39% |
Number of patients in different groups (%) with statistical significance (P).
a
Fraction of cases (%) with >5% of cells showing DNA content over 5c.